Chargement en cours...
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors, now make this therapy available to older people; however,...
Enregistré dans:
| Publié dans: | Blood Adv |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6737415/ https://ncbi.nlm.nih.gov/pubmed/31492679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000155 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|